People: Editas Medicine Inc (EDIT.OQ)
Dr. Charles Albright Ph.D., is a Chief Scientific Officer of the EDITAS MEDICINE, INC. since August 2016. Prior to joining Editas, Albright served in a variety of roles at Bristol-Myers Squibb Company, a biopharmaceutical company, from January 2004 to August 2016, serving most recently as the Vice President, Genetically Defined Diseases and Genomics. Dr. Albright received his B.S. in chemical engineering and a Ph.D. in biology from the Massachusetts Institute of Technology.
|Total Annual Compensation, USD||492,773|
|Restricted Stock Award, USD||--|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||773,862|
|Fiscal Year Total, USD||1,266,640|